Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arbidol plus oseltamivir versus oseltamivir alone for adult influenza pneumonia
ChiCTR1900028586Phase 4Recruiting
- Sponsor
- Shulan Health
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of umifenovir and oseltamivir in influenza pneumonia (2 arms), sponsored by Shulan Health. Primary endpoint: Influenza nucleic acid detection. Started Jan 2020; status: recruiting.
02
Drugs
umifenoviroseltamivir
03
Conditions
influenza pneumonia
Beyond the preview
Go deeper on ChiCTR1900028586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028586.